Palvella Therapeutics

(NASDAQ) PVLA

Current Price$125.53

Market Cap$1.75B

Since IPO (2024)+854%

5 YearN/A

1 Year+422%

1 Month+11%

Palvella Therapeutics Financials at a Glance

Market Cap

$1.75B

Revenue (TTM)

$0.00

Net Income (TTM)

$41.72M

EPS (TTM)

$-3.71

P/E Ratio

-33.03

Dividend

$0.00

Beta (Volatility)

1.09 (Average)

Dividend

$0.00

Beta (Volatility)

1.09 (Average)

Price

$125.53

Volume

417

Open

$125.14

Price

$125.53

Volume

417

Open

$125.14

Previous Close

$122.44

Daily Range

$124.41 - $126.28

52-Week Range

$20.20 - $151.18

Dividend

$0.00

Beta (Volatility)

1.09 (Average)

Price

$125.53

Volume

417

Open

$125.14

Previous Close

$122.44

Daily Range

$124.41 - $126.28

52-Week Range

$20.20 - $151.18

PVLA News

Palvella Stock Up 340% as Insider Sells Shares. Here's What the Move Does (And Does Not) Signal

Jonathan PoncianoMar 25, 2026

Director Buys $500,000 Worth of Palvella Therapeutics Shares After Phase 3 Win

Andy GouldMar 24, 2026

Palvella Posts Cash Gain and Trial Wins

Motley Fool Markets TeamAug 14, 2025

PVLA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Palvella Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Wesley H. Kaupinen, MBA

Website

www.palvellatx.com

Headquarters

Wayne, PA 19087, US

PVLA Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

-80%

Return on Assets

-70%

Earnings Yield

-3.03%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.75B

Shares Outstanding

14.31M

Volume

417

Avg. Volume

318.56K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$38.60M

EBITDA

$35.90M

Operating Cash Flow

$25.01M

Capital Expenditure

$0.00

Free Cash Flow

$25.01M

Cash & ST Invst.

$57.98M

Total Debt

$633.00K

Palvella Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$1.75B

N/A

Market Cap/Employee

$125.18M

N/A

Employees

N/A

Net Income

$12.71M

-221.8%

EBITDA

$10.97M

-151.4%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$57.35M

-31.4%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$431.00K

N/A

Short Term Debt

$202.00K

N/A

Return on Assets

-70.04%

N/A

Return on Invested Capital

-80.06%

N/A

Free Cash Flow

$4.93M

+8.7%

Operating Cash Flow

$4.93M

+8.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TYRATyra Biosciences, Inc.

TYRATyra Biosciences, Inc.$34.27+1.44%

NBTXNanobiotix S.A.

NBTXNanobiotix S.A.$33.62+1.91%

GHRSGH Research PLC

GHRSGH Research PLC$19.44+1.45%

EYPTEyePoint Pharmaceuticals, Inc.

EYPTEyePoint Pharmaceuticals, Inc.$12.94+0.63%

SVRASavara Inc.

SVRASavara Inc.$4.89+0.90%

ABUSArbutus Biopharma Corporation

ABUSArbutus Biopharma Corporation$4.16+0.81%

KURAKura Oncology, Inc.

KURAKura Oncology, Inc.$8.85+1.14%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$12.25-0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$53.79+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$11.72-0.02%

HTZHertz Global

HTZHertz Global$6.95+0.24%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.55+0.08%

OPENOpendoor Technologies

OPENOpendoor Technologies$5.14-0.08%

WULFTeraWulf

WULFTeraWulf$21.36+0.07%

Questions About PVLA

What is the current price of Palvella Therapeutics?

Palvella Therapeutics is trading at $125.53 per share.

What is the 52-week range for Palvella Therapeutics?

Over the past 52 weeks, Palvella Therapeutics has traded between $20.20 and $151.18.

How much debt does Palvella Therapeutics have?

As of the most recent reporting period, Palvella Therapeutics reported total debt of $18.39M.

How much cash does Palvella Therapeutics have on hand?

Palvella Therapeutics reported $57.98M in cash and cash equivalents in its most recent financial results.

What is Palvella Therapeutics’s dividend yield?

Palvella Therapeutics does not currently have a dividend yield.

Palvella Therapeutics

Palvella Therapeutics Financials at a Glance

PVLA News

Palvella Stock Up 340% as Insider Sells Shares. Here's What the Move Does (And Does Not) Signal

Director Buys $500,000 Worth of Palvella Therapeutics Shares After Phase 3 Win

Palvella Posts Cash Gain and Trial Wins

PVLA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Palvella Therapeutics

PVLA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Palvella Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PVLA

What is the current price of Palvella Therapeutics?

What is the 52-week range for Palvella Therapeutics?

How much debt does Palvella Therapeutics have?

How much cash does Palvella Therapeutics have on hand?

What is Palvella Therapeutics’s dividend yield?

Premium Investing Services